Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Facial discomfort, Feeling abnormal, Head discomfort, Muscle contractions involuntary, Musculoskeletal discomfort
Clinical narrative: Pulsing (fasciculation) under left eye.; Headaches like pressure for a week.; Lost appetite; Burps for 3-4 weeks.; Red, hot and swelling (2 inch in diameter) place of the injection site for a week.; Red, hot and swelling (2 inch in diameter) place of the injection site for a week.; Red, hot and swelling (2 inch in diameter) place of the injection site for a week.; Dizziness/fogginess; Dizziness/fogginess; Facial/neck rush; Facial/neck rush; Blood pressure raised to 150/90; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 14Jul2021 15:00 (Lot number: EW0187) at the age of 58 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Past drug history included: Epinephrine, reaction(s): "Allergy", notes: may be. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EW0186, Location of injection: Arm Right, Vaccine Administration Time: 03:15 PM), administration date: 23Jun2021, when the patient was 58 years old, for COVID-19 Immunization, reaction(s): "Red and itchy face", "Red and itchy face". The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The following information was reported: DIZZINESS (medically significant), FEELING ABNORMAL (medically significant) all with onset 14Jul2021 15:07, outcome "recovered" (2021) and all described as "Dizziness/fogginess"; FACIAL DISCOMFORT (medically significant), MUSCULOSKELETAL DISCOMFORT (medically significant) all with onset 14Jul2021 15:07, outcome "recovered" (2021) and all described as "Facial/neck rush"; BLOOD PRESSURE INCREASED (medically significant) with onset 14Jul2021 15:07, outcome "recovered" (2021), described as "Blood pressure raised to 150/90"; MUSCLE CONTRACTIONS INVOLUNTARY (medically significant) with onset 15Jul2021, outcome "recovered" (2021), described as "Pulsing (fasciculation) under left eye."; HEAD DISCOMFORT (medically significant) with onset 14Jul2021 15:15, outcome "recovered" (Jul2021), described as "Headaches like pressure for a week."; DECREASED APPETITE (medically significant) with onset 14Jul2021 15:15, outcome "recovered" (2021), described as "Lost appetite"; ERUCTATION (medically significant) with onset 14Jul2021 15:15, outcome "recovered" (2021), described as "Burps for 3-4 weeks."; VACCINATION SITE ERYTHEMA (medically significant), VACCINATION SITE WARMTH (medically significant), VACCINATION SITE SWELLING (medically significant) all with onset 14Jul2021 15:15, outcome "recovered" (Jul2021) and all described as "Red, hot and swelling (2 inch in diameter) place of the injection site for a week.". The events "dizziness/fogginess", "facial/neck rush", "facial/neck rush", "blood pressure raised to 150/90", "pulsing (fasciculation) under left eye.", "headaches like pressure for a week.", "lost appetite", "burps for 3-4 weeks.", "red, hot and swelling (2 inch in diameter) place of the injection site for a week.", "red, hot and swelling (2 inch in diameter) place of the injection site for a week." and "red, hot and swelling (2 inch in diameter) place of the injection site for a week." were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: blood pressure measurement: (unspecified date) 100-110/65-70, notes: Normal for me 100-110/65-70; (14Jul2021) 150/90. Therapeutic measures were taken as a result of dizziness, feeling abnormal, facial discomfort, musculoskeletal discomfort, blood pressure increased, muscle contractions involuntary, head discomfort, decreased appetite, eructation, vaccination site erythema, vaccination site warmth, vaccination site swelling. Clinical course included major adverse reaction was after the second shot that was done on 14Jul2021. 7 minutes after the 2nd dose of Pfizer vaccine felt dizziness/fogginess, had facial/neck rush. Blood pressure raised to 150/90. (Normal for me 100-110/65-70). Next day started pulsing (fasciculation) under left eye. Fasciculation under left eye could be fast or slow. It lasted for a week, then fasciculation was stopping and returning for the next several weeks. Had headaches like pressure for a week. Lost appetite, had burps for 3-4 weeks. Red, hot and swelling (2 inch in diameter) place of the injection site for a week. The patient was treated with Benadryl and observed after vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.